Effects of curcuminoid supplement on cardiac autonomic status in high-fat-induced obese rats

Nutrition

Volumn 25, Issue 7-8, 2009, Pages 870-878

  Pongchaidecha, Anchalee ^a,b   Lailerd, Narissara ^a,b   Boonprasert, Warasinee ^a,b   Chattipakorn, Nipon ^a,b  

^a THAMMASAT UNIVERSITY   (Thailand)

^b Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Curcuminoids; Heart rate variability; Obesity; Sympathovagal disturbance

Indexed keywords

CURCUMIN; CURCUMINOID; FATTY ACID; GLUCOSE; INSULIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC DYSFUNCTION; BODY WEIGHT; CALORIE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART DISEASE; HEART RATE VARIABILITY; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID DIET; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SUPPLEMENTATION; SYMPATHOVAGAL DISTURBANCE;

ANIMALS; ANTILIPEMIC AGENTS; BLOOD GLUCOSE; BODY WEIGHT; CURCUMA; CURCUMIN; DIET; ELECTROCARDIOGRAPHY; FATTY ACIDS, NONESTERIFIED; HEART RATE; INTRA-ABDOMINAL FAT; MALE; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; SYMPATHETIC NERVOUS SYSTEM; VAGUS NERVE;

CURCUMA LONGA; RATTUS; RATTUS NORVEGICUS;

EID: 67149094531     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.02.001     Document Type: Article

References (75)

1. Messerli F.H., Nunez B.D., Ventura H.O., and Snyder D.W. Overweight and sudden death. Increased ventricular ectopy in cardiopathy of obesity. Arch Intern Med 147 (1987) 1725-1728
2. Dustan H.P. Obesity and hypertension. Diabetes Care 14 (1991) 488-504
3. Modan M., and Halkin H. Hyperinsulinemia or increased sympathetic drive as links for obesity and hypertension. Diabetes Care 14 (1991) 470-487
4. DeFronzo R.A., and Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14 (1991) 173-194
5. Paolisso G., Gualdiero P., Manzella D., Rizzo M.R., Tagliamonte M.R., Gambardella A., et al. Association of fasting plasma free fatty acid concentration and frequency of ventricular premature complexes in nonischemic non-insulin-dependent diabetic patients. Am J Cardiol 80 (1997) 932-937
6. Laederach-Hofmann K., Mussgay L., and Ruddel H. Autonomic cardiovascular regulation in obesity. J Endocrinol 164 (2000) 59-66
7. Matsumoto T., Miyawaki C., Ue H., Kanda T., Yoshitake Y., and Moritani T. Comparison of thermogenic sympathetic response to food intake between obese and non-obese young women. Obes Res 9 (2001) 78-85
8. Grekin R.J., Vollmer A.P., and Sider R.S. Pressor effects of portal venous oleate infusion. A proposed mechanism for obesity hypertension. Hypertension 26 (1995) 193-198
9. Verwaerde P., Senard J.M., Galinier M., Rouge P., Massabuau P., Galitzky J., et al. Changes in short-term variability of blood pressure and heart rate during the development of obesity-associated hypertension in high-fat fed dogs. J Hypertens 17 (1999) 1135-1143
10. Chattipakorn N., Incharoen T., Kanlop N., and Chattipakorn S. Heart rate variability in myocardial infarction and heart failure. Int J Cardiol 120 (2007) 289-296
11. Tsuji H., Venditti Jr. F.J., Manders E.S., Evans J.C., Larson M.G., Feldman C.L., et al. Determinants of heart rate variability. J Am Coll Cardiol 28 (1996) 1539-1546
12. Kleiger R.E., Miller J.P., Bigger Jr. J.T., and Moss A.J. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59 (1987) 256-262
13. Tsuji H., Venditti Jr. F.J., Manders E.S., Evans J.C., Larson M.G., Feldman C.L., et al. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation 90 (1994) 878-883
14. Paolisso G., Manzella D., Rizzo M.R., Ragno E., Barbieri M., Varricchio G., et al. Elevated plasma fatty acid concentrations stimulate the cardiac autonomic nervous system in healthy subjects. Am J Clin Nutr 72 (2000) 723-730
15. Shaltout H.A., and Abdel-Rahman A.A. Mechanism of fatty acids induced suppression of cardiovascular reflexes in rats. J Pharmacol Exp Ther 314 (2005) 1328-1337
16. Ammon H.P., and Wahl M.A. Pharmacology of Curcuma longa. Planta Med 57 (1991) 1-7
17. Fu Y., Zheng S., Lin J., Ryerse J., and Chen A. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol 73 (2008) 399-409
18. Jacob A., Wu R., Zhou M., and Wang P. Mechanism of the anti-inflammatory effect of curcumin: PPAR-gamma activation. PPAR Res 2007 (2007) 89369
19. Manjunatha H., and Srinivasan K. Hypolipidemic and antioxidant effects of curcumin and capsaicin in high-fat-fed rats. Can J Physiol Pharmacol 85 (2007) 588-596
20. Menon V.P., and Sudheer A.R. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol 595 (2007) 105-125
21. Nishiyama T., Mae T., Kishida H., Tsukagawa M., Mimaki Y., Kuroda M., et al. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. J Agric Food Chem 53 (2005) 959-963
22. Reyes-Gordillo K., Segovia J., Shibayama M., Vergara P., Moreno M.G., and Muriel P. Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress. Biochim Biophys Acta 1770 (2007) 989-996
23. Chiu J., Khan Z.A., Farhangkhoee H., and Chakrabarti K. Curcumin prevents diabetes-associated abnormalities in the kidney by inhibiting p300 and nuclear kappa B. Nutrition (2009) in press
24. Memis D., Hekimoglu S., Sezer A., Altaner S., Sut N., and Usta U. Curcumin attenuates the organ dysfunction caused by endotoxemia in the rat. Nutrition 24 (2008) 1133-1138
25. Patil T.N., and Srinivasan M. Hypocholesteremic effect of curcumin in induced hypercholesteremic rats. Indian J Exp Biol 9 (1971) 167-169
26. Rao D.S., Sekhara N.C., Satyanarayana M.N., and Srinivasan M. Effect of curcumin on serum and liver cholesterol levels in the rat. J Nutr 100 (1970) 1307-1315
27. Asai A., and Miyazawa T. Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J Nutr 131 (2001) 2932-2935
28. Srinivasan K., Viswanad B., Asrat L., Kaul C.L., and Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 52 (2005) 313-320
29. Borst S.E., and Conover C.F. High-fat diet induces increased tissue expression of TNF-alpha. Life Sci 77 (2005) 2156-2165
30. Incharoen T., Thephinlap C., Srichairatanakool S., Chattipakorn S., Winichagoon P., Fucharoen S., et al. Heart rate variability in beta-thalassemic mice. Int J Cardiol 121 (2007) 203-204
31. Manzella D., Barbieri M., Rizzo M.R., Ragno E., Passariello N., Gambardella A., et al. Role of free fatty acids on cardiac autonomic nervous system in noninsulin-dependent diabetic patients: effects of metabolic control. J Clin Endocrinol Metab 86 (2001) 2769-2774
32. Langager A.M., Hammerberg B.E., Rotella D.L., and Stauss H.M. Very low-frequency blood pressure variability depends on voltage-gated L-type Ca2+ channels in conscious rats. Am J Physiol Heart Circ Physiol 292 (2007) H1321-H1327
33. Malik M., and Camm A.J. Components of heart rate variability-what they really mean and what we really measure. Am J Cardiol 72 (1993) 821-822
34. Akselrod S., Gordon D., Ubel F.A., Shannon D.C., Berger A.C., and Cohen R.J. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213 4504 (1981) 220-222
35. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
36. Jensen M.D., Haymond M.W., Rizza R.A., Cryer P.E., and Miles J.M. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 83 (1989) 1168-1173
37. Bergman R.N., and Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab 11 (2000) 351-356
38. Massillon D., Barzilai N., Hawkins M., Prus-Wertheimer D., and Rossetti L. Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion. Diabetes 46 (1997) 153-157
39. Roden M., Ludwig C., Nowotny P., Schneider B., Clodi M., Vierhapper H., et al. Relative hypoleptinemia in patients with type 1 and type 2 diabetes mellitus. Int J Obes Relat Metab Disord 24 (2000) 976-981
40. Chen X., Iqbal N., and Boden G. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 103 (1999) 365-372
41. Fanelli C., Calderone S., Epifano L., De Vincenzo A., Modarelli F., Pampanelli S., et al. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest 92 (1993) 1617-1622
42. Boden G. Effects of free fatty acids on gluconeogenesis and glycogenolysis. Life Sci 72 (2003) 977-988
43. Rigalleau V., Binnert C., Minehira K., Stefanoni N., Schneiter P., Henchoz E., et al. In normal men, free fatty acids reduce peripheral but not splanchnic glucose uptake. Diabetes 50 (2001) 727-732
44. Boden G., Chen X., Ruiz J., White J.V., and Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93 (1994) 2438-2446
45. Roden M., Price T.B., Perseghin G., Petersen K.F., Rothman D.L., Cline G.W., et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97 (1996) 2859-2865
46. Schmitz-Peiffer C., Browne C.L., Oakes N.D., Watkinson A., Chisholm D.J., Kraegen E.W., et al. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 46 (1997) 169-178
47. Shulman G.I. Cellular mechanisms of insulin resistance. J Clin Invest 106 (2000) 171-176
48. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46 (1997) 3-10
49. Crespin S.R., Greenough III W.B., and Steinberg D. Stimulation of insulin secretion by long-chain free fatty acids. A direct pancreatic effect. J Clin Invest 52 (1973) 1979-1984
50. Goberna R., Tamarit Jr. J., Osorio J., Fussganger R., Tamarit J., and Pfeiffer E.F. Action of B-hydroxy butyrate, acetoacetate and palmitate on the insulin release in the perfused isolated rat pancreas. Horm Metab Res 6 (1974) 256-260
51. Malik M., and Camm A.J. Components of heart rate variability-what they really mean and what we really measure. Am J Cardiol 72 (1993) 821-822
52. Pagani M., Lombardi F., Guzzetti S., Rimoldi O., Furlan R., Pizzinelli P., et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 59 (1986) 178-193
53. Malliani A., Pagani M., Lombardi F., and Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 84 (1991) 482-492
54. Grasso R., Schena F., Gulli G., and Cevese A. Does low-frequency variability of heart period reflect a specific parasympathetic mechanism?. J Auton Nerv Syst 63 (1997) 30-38
55. Gao Y.Y., Lovejoy J.C., Sparti A., Bray G.A., Keys L.K., and Partington C. Autonomic activity assessed by heart rate spectral analysis varies with fat distribution in obese women. Obes Res 4 (1996) 55-63
56. Peterson H.R., Rothschild M., Weinberg C.R., Fell R.D., McLeish K.R., and Pfeifer M.A. Body fat and the activity of the autonomic nervous system. N Engl J Med 318 (1988) 1077-1083
57. Zahorska-Markiewicz B., Kuagowska E., Kucio C., and Klin M. Heart rate variability in obesity. Int J Obes Relat Metab Disord 17 (1993) 21-23
58. Shishodia S., Sethi G., and Aggarwal B.B. Curcumin: getting back to the roots. Ann N Y Acad Sci 1056 (2005) 206-217
59. Kersten S., Desvergne B., and Wahli W. Roles of PPARs in health and disease. Nature 405 6785 (2000) 421-424
60. Xu J., Fu Y., and Chen A. Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am J Physiol Gastrointest Liver Physiol 285 (2003) G20-G30
61. Arun N., and Nalini N. Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum Nutr 57 (2002) 41-52
62. Kramer D., Shapiro R., Adler A., Bush E., and Rondinone C.M. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats. Metabolism 50 (2001) 1294-1300
63. Paolisso G., Gualdiero P., Manzella D., Gambardella A., Verza M., Gentile S., et al. Hyperinsulinemia is associated with ventricular premature complexes. Metabolism 45 (1996) 1248-1253
64. Boden G., and Chen X. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 96 (1995) 1261-1268
65. Sgoifo A., Koolhaas J.M., Musso E., and De Boer S.F. Different sympathovagal modulation of heart rate during social and nonsocial stress episodes in wild-type rats. Physiol Behav 67 (1999) 733-738
66. Maheshwari R.K., Singh A.K., Gaddipati J., and Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci 78 (2006) 2081-2087
67. Manzella D., Grella R., Marfella R., Giugliano D., and Paolisso G. Elevated post-prandial free fatty acids are associated with cardiac sympathetic overactivity in Type II diabetic patients. Diabetologia 45 (2002) 1737-1738
68. Reisin E., Frohlich E.D., Messerli F.H., Dreslinski G.R., Dunn F.G., Jones M.M., et al. Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med 98 (1983) 315-319
69. Sowers J.R., Whitfield L.A., Catania R.A., Stern N., Tuck M.L., Dornfeld L., et al. Role of the sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metab 54 (1982) 1181-1186
70. Young J.B., and Macdonald I.A. Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int J Obes Relat Metab Disord 16 (1992) 959-967
71. DeHaven J., Sherwin R., Hendler R., and Felig P. Nitrogen and sodium balance and sympathetic-nervous-system activity in obese subjects treated with a low-calorie protein or mixed diet. N Engl J Med 302 (1980) 477-482
72. Jung R.T., Shetty P.S., James W.P., Barrand M.A., and Callingham B.A. Reduced thermogenesis in obesity. Nature 279 5711 (1979) 322-323
73. Landsberg L., and Krieger D.R. Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens 2 3 pt 2 (1989) 125S-32
74. Levin B.E., Triscari J., and Sullivan A.C. Defective catecholamine metabolism in peripheral organs of genetically obese Zucker rats. Brain Res 224 (1981) 353-366
75. Young J.B., Saville E., Rothwell N.J., Stock M.J., and Landsberg L. Effect of diet and cold exposure on norepinephrine turnover in brown adipose tissue of the rat. J Clin Invest 69 (1982) 1061-1071